Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population

By Mitchell Cathrine   Gregersen Nerine   Krause Amanda  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 953-963

Future Medicine

Access to resources Recommend Favorite

The Gateway Hypothesis of Substance Abuse: An Examination of Its Applicability in the Nigerian General Population

By Makanjuola Victor Adesola   Oladeji Bibilola Damilola   Gureje Oye  

Substance Use & Misuse, Vol. 45, Iss. 10, 2010-06 ,pp. : 1558-1571

Informa Healthcare

Access to resources Recommend Favorite

The Applicability and Generalizability of Findings from Clinical Trials for Health-Policy Decisions

By Freemantle Nick   Hessel Franz  

PharmacoEconomics, Vol. 27, Iss. 1, 2009-01 ,pp. : 5-10

Adis International

Access to resources Recommend Favorite

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity

By Dandara Collet   Lombard Zané   Du Plooy Ingrid   McLellan Tracy   Norris Shane A   Ramsay Michèle  

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1663-1670

Future Medicine

Access to resources Recommend Favorite

Intradermal vs percutaneous BCG in South African infants

By  

Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite